Barinthus Biotherapeutics plc

    Jurisdiction
    United Kingdom
    LEI
    213800KQ9EAOKPWN8A33
    ISIN
    US91864C1071 (BRNS)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9

    Profile

    Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €25.10M
    Gross margin
    77.4%
    EBIT
    €56.56M
    EBIT margin
    225.3%
    Net income
    -€46.41M
    Net margin
    -184.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    N/A -€55.64M +19.9%
    N/A -€57.21M +2.8%
    N/A N/A

    Dividends

    No dividend payouts

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 36K $34.73K +600 Buy

    Add to watchlist

    Notifications